Skip to content
LexBuild

Importer of Controlled Substances; Notice of Application; Stepan Company

---
identifier: "/us/fr/2012-12248"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Importer of Controlled Substances; Notice of Application; Stepan Company"
title_number: 0
title_name: "Federal Register"
section_number: "2012-12248"
section_name: "Importer of Controlled Substances; Notice of Application; Stepan Company"
positive_law: false
currency: "2012-05-21"
last_updated: "2012-05-21"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "2012-12248"
document_type: "notice"
publication_date: "2012-05-21"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "77 FR 30025"
fr_volume: 77
---

#  Importer of Controlled Substances; Notice of Application; Stepan Company

This is notice that on February 27, 2012, Stepan Company, Natural Products Department, 100 W. Hunter Avenue, Maywood, New Jersey 07607, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of Coca Leaves (9040), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance to manufacture bulk controlled substance for distribution to its customer.

Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (2007).

As noted in a previous notice published in the *Federal Register* on September 23, 1975, 40 FR 43745, all applicants for registration to import a basic class of any controlled substance in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.

Dated: May 11, 2012.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.